Use of Jeevanti Arka eye drops in allergic conjunctivitis

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2026
INTERVENTION: CONDITION: Health Condition 1: H108‐ Other conjunctivitis PRIMARY OUTCOME: The results of Jeevanti Arka and eye drop Olopatadine Hydrochloride ; Ophthalmic Solution Ip 0 1 maybe comparableTimepoint: 0th day 15th day 30th day 45th day SECONDARY OUTCOME: nilTimepoint: nil INCLUSION CRITERIA: Subjects presenting with signs and symptoms of Simple Allergic Conjunctivitis and fulfilling the diagnostic criteria
Epistemonikos ID: 61b53ef98ace594d8df114dc2a0afbf7265ed0ec
First added on: Oct 08, 2026